Literature DB >> 10693762

A role for CaMKII in T cell memory.

J D Bui1, S Calbo, K Hayden-Martinez, L P Kane, P Gardner, S M Hedrick.   

Abstract

In order to study the role of calcium/calmodulin kinase II (CaMKII) in T cells, we generated transgenic mice expressing CaMKIIgammaB* (T287D), a partially calcium-independent mutant of CaMKIIgammaB. In these mice, the size of the thymus was increased 1.5- to 2-fold, at least in part due to an increase in the lifespan of double-positive (DP) thymocytes. More importantly, there was an increase in the number of T cells in the secondary lymphoid organs that had acquired an antigen-dependent memory phenotype. These T cells were bonafide memory cells as assessed by a variety of criteria. In addition, T cells from wild-type mice acquired calcium-independent CaMKII activity after several rounds of antigen-stimulated division. We propose that CaMKII controls a distinct process of activation-induced cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10693762     DOI: 10.1016/s0092-8674(00)80681-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  20 in total

Review 1.  The regulation of dendritic cell function by calcium-signaling and its inhibition by microbial pathogens.

Authors:  S F Connolly; D J Kusner
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation.

Authors:  Jutong Si; Steven J Collins
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

3.  Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation.

Authors:  Kazuhiro Ishiguro; Todd Green; Joseph Rapley; Heather Wachtel; Cosmas Giallourakis; Aimee Landry; Zhifang Cao; Naifang Lu; Ando Takafumi; Hidemi Goto; Mark J Daly; Ramnik J Xavier
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma.

Authors:  Ying Gu; Jiawei Zhang; Xiaoxiao Ma; Byung-Wook Kim; Hailong Wang; Jinfan Li; Yi Pan; Yang Xu; Lili Ding; Lu Yang; Chao Guo; Xiwei Wu; Jun Wu; Kirk Wu; Xiaoxian Gan; Gang Li; Ling Li; Stephen J Forman; Wing-Chung Chan; Rongzhen Xu; Wendong Huang
Journal:  Cancer Cell       Date:  2017-07-10       Impact factor: 31.743

5.  Rapamycin inhibits B-cell activating factor (BAFF)-stimulated cell proliferation and survival by suppressing Ca2+-CaMKII-dependent PTEN/Akt-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells.

Authors:  Qingyu Zeng; Zhihan Zhou; Shanshan Qin; Yajie Yao; Jiamin Qin; Hai Zhang; Ruijie Zhang; Chong Xu; Shuangquan Zhang; Shile Huang; Long Chen
Journal:  Cell Calcium       Date:  2020-02-07       Impact factor: 6.817

6.  Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.

Authors:  Zhipeng Meng; Tao Li; Xiaoxiao Ma; Xiaoqiong Wang; Carl Van Ness; Yichao Gan; Hong Zhou; Jinfen Tang; Guiyu Lou; Yafan Wang; Jun Wu; Yun Yen; Rongzhen Xu; Wendong Huang
Journal:  Mol Cancer Ther       Date:  2013-08-19       Impact factor: 6.261

7.  BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells.

Authors:  Dingfang Liang; Qingyu Zeng; Zhigang Xu; Hai Zhang; Lin Gui; Chong Xu; Sujuan Chen; Shuangquan Zhang; Shile Huang; Long Chen
Journal:  Biochem Pharmacol       Date:  2013-11-22       Impact factor: 5.858

8.  BAFF inhibits autophagy promoting cell proliferation and survival by activating Ca2+-CaMKII-dependent Akt/mTOR signaling pathway in normal and neoplastic B-lymphoid cells.

Authors:  Xiaoqing Dong; Jiamin Qin; Jing Ma; Qingyu Zeng; Hai Zhang; Ruijie Zhang; Chunxiao Liu; Chong Xu; Shuangquan Zhang; Shile Huang; Long Chen
Journal:  Cell Signal       Date:  2018-09-20       Impact factor: 4.315

9.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

Review 10.  The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders.

Authors:  Kinga Sałaciak; Aleksandra Koszałka; Elżbieta Żmudzka; Karolina Pytka
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.